I.Full Description of Methods

Animals
All animals were kept on a 12-h light/dark cycle in a temperature-controlled room with ad libitum access to food and water. All animal were treated in compliance with the USA National Institute of Health Guideline for Care and Use of Laboratory Animals. Genotyping information is provided in the inserted figure and in supplementary Table S1 .
Induction and Quantification of Recombination
Tamoxifen (Cat#: T5648, Sigma-Aldrich, St. Louis, MO, USA) was dissolved in warm sunflower seed oil at a concentration of 10 mg/ml and injected intraperitoneally (i.p.) at 20 mg/kg body weight daily for 3 wks to avoid the cardiac Cre toxicity as previously reported. 2 The induction of recombination with tamoxifen was started in male mice at 6 wks of age. After a time period of 2 wks for washing out the tamoxifen, the efficacy of The sham or TAC operation in mice was performed under deep anesthesia as previously described. 3 Briefly, mice were anesthetized by i.p. injection of ketamine (80 mg/kg) and xylazine (5 mg/kg). The use of a horizontal incision at the level of the suprasternal notch allows direct visualization of the transverse aorta without entering the pleural space and thus obviates the need for mechanical ventilation. The transverse aorta was banded between the right innominate and left carotid arteries to a 27-gauge needle using a 6-0 nylon silk suture. Sham operation on mice were similar but without actual aortic banding and these mice served as a control group for all experimental groups. Cardiac hypertrophy was determined by heart weight-to-tibial length (HW/TIBIA) ratio, heart weight-to-body weight (HW/BW) ratio and expression levels of cardiac hypertrophy marker genes including atrial natriuretic factor (ANF), brain natriuretic peptide (BNP), alpha-myosin heavy chain (α-MHC), beta-myosin heavy chain (β-MHC), sarco-endoplasmic reticulum calcium ATPase2a (SERCA2a).
Echocardiographic Analysis
Echocardiography was performed on anesthetized mice, using the Vevo 2100 High-Resolution Imaging System (VisualSonics Inc.) with a 30-MHz high-frequency linear transducer, as previously described. 1 Briefly, mice were anesthetized with 3% isoflurane and maintained with 1.5% isoflurane in room air supplemented with 100% O 2 . After the anterior chest was shaved, the animals were placed on a warming pad to maintain normothermia. The echocardiographic gel was warmed before use to avoid hypothermia. Care was taken to avoid excessive pressure on the thorax, which can induce bradycardia. Two-dimensional (2D) long axis images of the left ventricle (LV) were obtained at the plane of the aortic and mitral valves where the LV cavity is largest and visualization of the LV apex is adequate, and a short-axis image was recorded at the level of the papillary muscles. A 2D guided M-mode echocardiogram was recorded through the anterior and posterior LV walls at 21 frames/s. Images were obtained at the level of the papillary muscle tips, and measurements were then performed to obtain the LV internal dimension (LVID; in mm), interventricular septum thickness (IVS), and LV posterior wall thickness (LVPW; in mm). LV percent fractional shortening FS (%) was calculated via VisualSonics Measurement Software.
Pathology
Mice were anesthetized and the hearts perfused via the abdominal aorta with a saline solution to remove the blood from the heart tissue. Then, the heart was dried on gauze, weighed, dissected, and frozen. Lungs and tibias were also dissected. Lungs were dried on gauze and weighed. The length of the tibia from the condyles to the tip of the medial malleolus was measured by micrometer calipers.
Evens Blue Labelling
Evans blue dye becomes intensely red fluorescent when conjugated to albumin in the circulation. The dye/albumin complexes are excluded from cells with intact plasma membranes while accumulating in damaged myofibers when the muscle cell membrane is broken, thus providing a dye-exclusion viability test. The red auto-fluorescence accumulated in myocardium has been used as a histopathological sign of cardiomyocyte necrosis. 
Histological and Immunochemical Analysis
Hearts were cannulated via the LV apex, cleared of blood by perfusion with normal saline at 90 mmHg, arrested in diastole with 60 mM KCl, fixed by perfusion with 4% paraformaldehyde, and embedded in paraffin. Paraffin sections were prepared (5 μm, Leica RM2235, rotary microtome) and stored at room temperature until staining. For LV cardiomyocyte cross-sectional area, coronal sections were deparaffinized and the cardiomyocyte membranes were stained with Alexa Fluor 488 conjugated wheat germ agglutinin (WGA) (Invitrogen Corp., Carlsbad, CA) and observed using a fluorescence microscope (Nikon Eclipse 80i; Nikon Instruments Inc. Tokyo, Japan) at 400× magnification. Twenty fields of each section were randomly photographed using NIS-Elements F 4.0 imaging software (Nikon Instruments Inc. Tokyo, Japan) and cross sectional areas of 1000-1400 circular cardiomyocytes per heart was measured using Image-Pro Plus software (Media Cybernetics, Inc., Bethesda, MD, USA). For myocardial fibrosis, coronal sections were stained for collagen with a Masson's Trichrome Kit (Poly Scientific, Bay Shore, NY, USA) according to the protocol provided by the manufacturer. Sections were observed under a light microscope (Nikon Eclipse 80i; Nikon Instruments Inc. Tokyo, Japan) at 200 × magnification. Twenty fields of each section were randomly photographed using NIS-Elements F 4.0 imaging software (Nikon Instruments Inc. Tokyo, Japan). The percentage of fibrosis (the blue stained area) was measured by Image-Pro Plus software (Media Cybernetics, Inc., Bethesda, MD, USA). At least two sections of each heart were analyzed for the measurements of cardiomyocyte cross sectional areas and cardiac fibrosis. Apoptosis was measured by TUNEL assays on tissue sections using In Situ Cell Death Detection Kit, TMR red (Roche Applied Science, Indianapolis, IN, USA) according to the protocol provided by the manufacturer. Briefly, the sections were deparaffinized, rehydrated, microwaved in 0.01 M citrate buffer for 30 mins, and incubated in 0.3% triton X-100 in PBS for 30 mins. They were then incubated with 50 μl of TUNEL Reaction Mixture at 37ºC for 1 h and mounted with Prolong Gold Antifade Reagent and DAPI (Invitrogen Corp., Carlsbad, CA). A positive control section was digested with DNase (RNase-Free DNase Set, QIAGEN Inc., Valencia CA) for 30 min and a negative control section was only incubated with labeling solution (without enzyme solution). The apoptotic nuclei were labeled with TUNEL (red) all nuclei were counterstained with DAPI (blue). TUNEL-positive cells were quantified in all nuclei of a LV section. At least two sections from each heart were analyzed.
Myocardial oxidative stress was assessed by staining of 8-hydroxydeoxyguanosine (8-OHdG), a marker of DNA oxidization, with a mouse anti 8-OHdG antibody (Cat#: sc-660369, Santa Cruz Biotechnology, Inc., Dallas, Texas, USA). Numbers of 8-OHdG positive nuclei were counted in 8 randomly chosen fields of each tissue section. Two sections from each heart were analyzed. Sub-cellular locations of p-Erk, p-Fyn, and Nrf2 were analyzed by immunochemical staining using anti-p-Erk (cat#: 9101, Cell Signaling Technology, Inc., Danvers, Massachusetts, USA), anti-p-Fyn (cat#: sc-16848, Santa Cruz Biotechnology, Inc., Dallas, Texas, USA), and anti-Nrf2 (cat#: sc-722, 1:200, Santa Cruz Biotechnology Inc., Dallas, Texas, USA). Two sections from each heart were analyzed.
Cell Cultures, Adenoviral Infection, Oligo and Plasmid Transfection
Rat neonatal cardiac myocytes were isolated and cultured as previously described. 3 Adenovirus of control scramble shRNA (Ad-shCtr) and rat Nrf2 shRNA (Ad-shNrf2) were generated as previously reported. 3 Rat neonatal cardiomyocytes were infected with Ad-shCtr (20 MOI) and Ad-shNrf2 (20 MOI) in serum-free DMEM for 6 h and the cultured with full growth medium (1 g/L glucose DMEM supplemented with 8% horse serum (HS) and 5% newborn calf serum (NCS) for additional 24 h. The infected cardiomyocytes were further transfected with scramble siRNA (siCtr, sense, 5'-UCUCCGAACGUGUCACGU -3'; antisense, 5'-AAGAGGCUUGCACAGUGCA -3', purchased from Invitrogen Corp., Carlsbad, CA), Agt5 siRNA (siAtg5, sense 5'-GCGGATTCCAACGTGCTTTA -3'; antisense,, 5'-TAAAGCACGTTGGAATCCGC -3' purchased from Ribobio, Guangzhou, China) using Lipofectamine 2000 (Cat#: 12566-014, Thermo Fisher Scientific, Waltham, USA) for 6 h and then cultured with full growth medium aforementioned for 24 h. The transfection was repeated once and then the cells were serum starved for 48 h prior to the treatment with Ang II (1 µM, Cat#: RAB0010, Sigma-Aldrich, St. Louis, MO, USA) and PP2 (1 µM, Fyn kinase inhibitor, Cat#: P0042, Sigma-Aldrich, St. Louis, MO, USA) in serum free DMEM. Based on our pilot study that Ang II stimulation induced phosphorylation of Jak2, Stat3, and Fyn, and upregulation of LC3-II at 24 h while enhancing protein expression of Agt at 48 h in rat neonatal cardiomyocytes (data not shown), we treated the cardiomyocytes with Ang II for 24 h prior to Western blot analysis of Jak2, Stat3, and Fyn phosphorylation, and LC3-II protein expression, and for 48 h prior to Western blot analysis of Agt protein expression. For qPCR analysis of the effect of PP2 (1 µM) and AG490 (a Jak2 inhibitor, 1 µM, Cat#: T3434, Sigma-Aldrich, St. Louis, MO, USA) on Ang II-induced mRNA expression of NQO1 and Agt, we treated serum starved cardiomyocytes in serum free DMEM as indicated for 48 h. These experiments were repeated for 4 times.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and Quantitative Real Time (qPCR)
The total RNA from the LV was extracted using RNeasy Fibrous Tissue Mini kit (Qiagen Inc., Valencia, CA), and the reverse transcription reaction was performed with 1 µg of total RNA using a RevertAid TM First Strand cDNA Synthesis Kit (Cat#: K1622, Thermo Scientific). qPCR was carried out using the Bio-Red CFX96 TM Real-Time system (C1000 TM Thermal Cycler, Bio-Red Laboratories, Inc. Hercules, CA, US). Expression levels of target genes were normalized by concurrent measurement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels. Primers that were used for qPCR are summarized in supplementary Table S1 . Genomic DNAs were also extracted from mouse tails and subjected to PCR for genotyping of transgene mice.
Autophagy Flux Assay
A cohort of male WT mice (C57BL/6J) at ages of 9-10 wks were subjected to sham or TAC operations. It has been reported that intraperitoneal (i.p.) injection of chloroquine (CQ, 10 mg/kg), or rapamycin (2 mg/kg), or rapamycin plus chloroquine for 4 h induce accumulation of mCheery-LC3 in the heart of transgenic mice expressing mCherry-LC3. 4 These results suggest that the differences between the basal and CQ-induced or the rapamycin-induced and rapamycin plus CQ-induced LC3 protein expression could be quantified as autophagic flux, a more accurate parameter reflecting autophagic activity. 5 We performed preliminary experiments to verify the efficacy of these treatments on LC3 expression in the murine heart. We found that the myocardial expression level of LC3 was hardly affected by 4 h of i.p. injection of (CQ, 10 mg/kg) or rapamycin (2 mg/kg), respectively (data not shown). However, i.p. injection of rapamycin (2 mg/kg) plus CQ (10 mg/kg) for 4 h induced a clear increase in LC3 protein expression in the heart. 1 Hence, the mice before (0 wk) and at 1, 2, 4, 8 wks after operation were i.p. injected with rapamycin (2 mg/kg) with vehicle or chroloquine (CQ, 10 mg/kg) for 4 h prior to the autophagy flux assay. 1 LV lysates were subjected to Western blot analysis of LC3-I and LC3-II protein levels. Autophagic flux is defined as the amount of CQ-induced accumulation of LC3-II which is calculated by a formula of (rapamycin + CQ)-induced LC3-II density -(rapamycin-induced) LC3-II density.
Western Blot Analysis LV tissues were lysed in a homogenization buffer (RIPA) contained 150 mM NaCl, 1% NP-40, 50 mM Tris (pH 8.0), 0.5% sodium deoxycholate (C 24 H 39 NaO 4 ), 0.1% sodium dodecyl sulfate (SDS), 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM sodium orthovanadate (Na 3 VO 4 ), and proteinase inhibitor cocktail (Roche, Basel, Switzerland). Immunoblotting was conducted as described elsewhere. 1, 3 Antibodies used included
